Vogt-Koyanagi-Harada-like syndrome induced by immune checkpoint inhibitors in a patient with melanoma

Clin Exp Dermatol. 2020 Oct;45(7):908-911. doi: 10.1111/ced.14282. Epub 2020 Jul 5.

Authors

S Yoshida¹, K Shiraishi¹, T Mito², K Sayama¹

Affiliations

¹ Departments of, Department of, Dermatology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
² Department of, Ophthalmology, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.

PMID: 32394515
DOI: 10.1111/ced.14282

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Antineoplastic Agents, Immunological / adverse effects
Humans
Immune Checkpoint Inhibitors / adverse effects*
Immune Checkpoint Inhibitors / therapeutic use
Ipilimumab / adverse effects*
Ipilimumab / therapeutic use
Male
Melanoma / drug therapy*
Middle Aged
Triamcinolone Acetonide / administration & dosage
Uveomeningoencephalitic Syndrome / chemically induced*
Uveomeningoencephalitic Syndrome / drug therapy
Vitiligo / chemically induced

Substances

Antibodies, Monoclonal, Humanized
Antineoplastic Agents, Immunological
Immune Checkpoint Inhibitors
Ipilimumab
pembrolizumab
Triamcinolone Acetonide